PTON's liquidation posture remains deeply negative. As of March 31, 2026, total GAAP assets of $2.02B are opposed by total liabilities of $2.26B, producing a book equity deficit of $241.9M. Under liquidation haircuts, the recovery picture is substantially worse. Cash and restricted cash of approximately $1.17B recover at par. Accounts receivable of $78.6M recover at roughly $71M-$75M (90-95%). Inventory of $175.8M net (against a $88.7M valuation reserve already applied) recovers at 60%, yielding roughly $105M. PP&E net of $175.9M recovers at 50-70%, yielding $88M-$123M. Goodwill of $44.0M and intangibles of $0.2M recover at zero. Operating lease ROU assets of $295.6M are not separately realizable; the corresponding lease liabilities of $429.9M ($65.0M current plus $364.9M noncurrent) remain at face value and must be settled. Combined debt face value is $1.332B ($982.5M term loan plus $350M 2029 convertible notes), which stays at face. Minimum royalty commitments ($122.1M total), other purchase obligations ($153.3M), and contract manufacturer commitments ($48.3M) do not extinguish on windup. Total contractual obligations disclosed in MD&A sum to $2.16B. On even an optimistic asset recovery scenario, liquidation value to equity is deeply negative, consistent with MFFAIS CLV of approximately -$1.14B. The key change from the prior filing (December 31, 2025) is the retirement of the $199M remaining 2026 Notes in Q3 FY2026, which reduced total convertible debt outstanding from $549M to $350M but consumed cash: cash declined from $1.18B to $1.13B. Financing outflows of $203.8M for the nine months ended March 31, 2026 reflect this paydown. Offsetting, operating cash generation of $296.5M for the nine-month period meaningfully exceeded the prior-year $215.9M, supported by continued cost reduction (impairment, D&A, and G&A all lower year-over-year). Ongoing restructuring charges of $11.2M (nine-month YTD) and lease exit activity are reducing the real estate footprint, modestly lowering the lease liability stack from $575.2M (December 31, 2025) to $551.3M at March 31, 2026. Accumulated deficit stands at $5.601B. The filing does not separately XBRL-tag the $48.3M manufacturer purchase commitment or the $122.1M minimum royalty obligation; these appear only in the MD&A contractual obligations table.
▼ Community Notes